iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Zydus receives USFDA final approval for Acetaminophen injection

1 Nov 2022 , 01:31 AM

Zydus Lifesciences has received final approval from the United States Food and Drug Administration USFDA to market Acetaminophen Injection 1000 mg100 mL 10 mgmL single-dose vials USRLD Ofirmev Acetaminophen injection is indicated to relieve mild to moderate pain and to reduce fever It is also used in combination with opioid narcotic medications to relieve moderate to severe pain The drug will be manufactured at the groups injectable manufacturing facility at Jarod near Vadodara India Acetaminophen injection had annual sales of USD 72 mn in the United States according to IQVIA data IQVIA MAT Aug 2022

Related Tags

  • Announcements
  • BSE
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.